Family Indicates Man Committed Suicide Because of Propecia

An emergency room doctor alleges that his son committed suicide because of Propecia side effects, after he was left impotent by Merck’s medication for treatment of male hair loss.

Dr. John Santmann joined a protest over Propecia last month outside of Merck & Co.’s New Jersey headquarters, which was designed to bring attention to the company’s inaction in addressing problems with Propecia, which could include permanent erectile dysfunction, loss of libido and depression.

Randy Santmann killed himself in 2008, at the age of 22, after taking Propecia for three years and developing sexual problems from the medication that continued at least six months after he stopped using the drug, according to his family.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Propecia (finasteride) is a prescription medication approved to help restore natural hair loss that occurs in some men. While the warning label has indicated that some men developed erectile dysfunction and other sexual side effects, until recently, the drug maker suggested that such problems resolve when the medication is no longer used.

Although Merck updated the warnings provided in several other countries to indicate that some men reported suffering persistent sexual side effects from Propecia after the hair-loss drug was no longer used, they resisted updating the warnings provided in the United States until April 2012.

A number of men throughout the United States are now pursuing a Propecia lawsuit against Merck for failing to adequately warn about the risks associated with the medication.  Many plaintiffs allege that if they had been provided with accurate information about the risk of long-term sexual dysfunction, they never would have taken the prescription drug to help restore hair loss and improve their appearance.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Plaintiffs and defendants involved in a Galaxy Gas nitrous oxide lawsuit will meet with a federal judge early next month as the litigation continues to move forward.
Plastic surgeons are sounding the alarm over the rising use of mesh-based “internal bra” procedures, warning that the materials may cause serious complications and provide little long-term benefit.
Parties involved in hair relaxer cancer lawsuits meet with a federal judge tomorrow to update the Court on the status of discovery proceedings ahead of bellwether lawsuits.